# Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure

Study · id `cardio:ct-nct07929467` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07929467](<https://clinicaltrials.gov/study/NCT07929467>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07929467

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 760 participants.

## Technical summary

Registry record NCT07929467. Randomized; no masking; primary purpose treatment. Start 2027-11 (anticipated); primary completion 2029-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 760 participants (planned count; ClinicalTrials.gov record NCT07929467, source copy `cardio:ctgov-nct07929467-2026-11-10`, retrieved 2026-11-18)
- Planned start: 2027-11 (anticipated) (ClinicalTrials.gov record NCT07929467, source copy `cardio:ctgov-nct07929467-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT07929467, source copy `cardio:ctgov-nct07929467-2026-11-10`, retrieved 2026-11-18)
- Completion: 2029-12 (anticipated) (ClinicalTrials.gov record NCT07929467, source copy `cardio:ctgov-nct07929467-2026-11-10`, retrieved 2026-11-18)
- Countries: Austria (ClinicalTrials.gov record NCT07929467, source copy `cardio:ctgov-nct07929467-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07929467-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart Failure
- Acronym: LEAP HF
- Condition: Bradycardia
- Condition: Atrioventricular Block
- Condition: Heart Failure
- Condition: Pacing Induced Cardiomyopathy
- Condition: Pacing Therapy
- Condition: Pacing Induced Dyssynchrony
- Condition: Leadless Pacemaker
- Intervention (Device): Leadless pacemaker implantation
- Intervention (Device): Conventional transvenous pacemaker implantation
- Lead sponsor: Karl Landsteiner University of Health Sciences
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: d035ca0ef4182d9335a36b3b20e1b725acd1673406bf948efbaf463482c96312
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
